Effects of sugammadex on immunoreactivity of calcineurin in rat testes cells after neuromuscular block: a pilot study

[1]  N. Pham,et al.  Drug‐specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  J. Egmond,et al.  Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats , 2011, Journal of Anesthesia.

[3]  J. Smeets,et al.  Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects , 2010, Clinical drug investigation.

[4]  B. Plaud,et al.  Sugammadex in anesthesia practice , 2010, Expert opinion on pharmacotherapy.

[5]  M. W. van den Heuvel,et al.  Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study. , 2010, Clinical drug investigation.

[6]  H. D. Boer.  Neuromuscular transmission: New concepts and agents , 2009 .

[7]  H. D. de Boer.  Neuromuscular transmission: new concepts and agents. , 2009, Journal of critical care.

[8]  R. Soto,et al.  Reversal of Profound Rocuronium-induced Blockade with Sugammadex: A Randomized Comparison with Neostigmine , 2008, Anesthesiology.

[9]  J. van Egmond,et al.  Update on the management of neuromuscular block: focus on sugammadex , 2007, Neuropsychiatric disease and treatment.

[10]  P. Rocco,et al.  Anaesthetic management in asthma. , 2007, Minerva anestesiologica.

[11]  M. Naguib.  Sugammadex: another milestone in clinical neuromuscular pharmacology. , 2007, Anesthesia and analgesia.

[12]  J. Stensballe,et al.  Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex: A Dose-finding and Safety Study , 2006, Anesthesiology.

[13]  J. Gooch.  An emerging role for calcineurin Aalpha in the development and function of the kidney. , 2006, American journal of physiology. Renal physiology.

[14]  J. van Egmond,et al.  Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. , 2006, British journal of anaesthesia.

[15]  D. Singh,et al.  ANAESTHETIC MANAGEMENT OF , 2006 .

[16]  C. Baillard,et al.  Postoperative residual neuromuscular block: a survey of management. , 2005, British journal of anaesthesia.

[17]  S. Ramael,et al.  First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide , 2005, Anesthesiology.

[18]  C. Zouboulis,et al.  Influence of physiological androgen levels on wound healing and immune status in men , 2005, The aging male : the official journal of the International Society for the Study of the Aging Male.

[19]  K. Fujinaga,et al.  Immunohistochemical localization of the calcium/calmodulin-dependent protein phosphatase, calcineurin, in the mouse testis: its unique accumulation in spermatid nuclei , 1995, Cell and Tissue Research.

[20]  A. Bom,et al.  Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. , 2002, Journal of medicinal chemistry.

[21]  Mark Bradley,et al.  A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. , 2002, Angewandte Chemie.

[22]  A. Bergh,et al.  Effects of Acute Graded Reductions in Testicular Blood Flow on Testicular Morphology in the Adult Rat1 , 2001, Biology of reproduction.

[23]  H. Nishio,et al.  Immunolocalization of calcineurin and FKBP12, the FK506-binding protein, in Hassall's corpuscles of human thymus and epidermis , 2000, Histochemistry and Cell Biology.

[24]  T. Kamata,et al.  T Cell Receptor–Induced Calcineurin Activation Regulates T Helper Type 2 Cell Development by Modifying the Interleukin 4 Receptor Signaling Complex , 2000, The Journal of experimental medicine.

[25]  C. Baillard,et al.  Residual curarization in the recovery room after vecuronium. , 2000, British journal of anaesthesia.

[26]  P. Mertz,et al.  Calcineurin: form and function. , 2000, Physiological reviews.

[27]  B. Ryffel,et al.  Distribution and activity of calcineurin in rat tissues. Evidence for post-transcriptional regulation of testis-specific calcineurin B. , 1995, European journal of biochemistry.

[28]  宮本 一広.  In situ localization of rat testis-specific calcineurin B subunit isoform β1 in the developing rat testis , 1995 .

[29]  H. Matsui,et al.  In situ localization of rat testis-specific calcineurin B subunit isoform beta 1 in the developing rat testis. , 1994, Biochemical and biophysical research communications.

[30]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[31]  J. Bancroft,et al.  Theory and Practice of Histological Techniques , 1990 .

[32]  C. Klee,et al.  Identification, characterization, and functional correlation of calmodulin-dependent protein phosphatase in sperm , 1988, The Journal of cell biology.

[33]  B L Langille,et al.  Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. , 1986, Science.

[34]  A. Baumgarten.  Vascular Permeability Responses in Hypersensitivity: III. Reaction to Human Immunoglobulin , 1970, Pathology.